GH Research PLC (NASDAQ:GHRS - Get Free Report)'s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $17.99, but opened at $19.19. GH Research shares last traded at $16.65, with a volume of 157,728 shares trading hands.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on GHRS shares. HC Wainwright restated a "buy" rating and issued a $40.00 price target on shares of GH Research in a research note on Monday, January 27th. Canaccord Genuity Group decreased their target price on GH Research from $31.00 to $28.00 and set a "buy" rating on the stock in a research report on Monday, November 18th.
View Our Latest Research Report on GH Research
GH Research Trading Up 1.8 %
The business has a 50-day moving average of $9.03 and a two-hundred day moving average of $9.01. The firm has a market cap of $735.08 million, a P/E ratio of -17.88 and a beta of 0.93.
Hedge Funds Weigh In On GH Research
An institutional investor recently raised its position in GH Research stock. RA Capital Management L.P. boosted its stake in shares of GH Research PLC (NASDAQ:GHRS - Free Report) by 1.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,686,689 shares of the company's stock after buying an additional 85,000 shares during the quarter. RA Capital Management L.P. owned approximately 12.85% of GH Research worth $44,734,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 56.90% of the company's stock.
About GH Research
(
Get Free Report)
GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).
Read More
Before you consider GH Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GH Research wasn't on the list.
While GH Research currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
